The biotech's investigational weight loss drug did very well in a clinical trial. This is a white-hot segment of the pharmaceutical market, so it's little wonder investors subsequently pounced on the ...

Quebecor (TSX:QBR.B) has gone parabolic (≈+62% YTD) but still looks like an attractive mid‑cap growth/dividend‑growth pick ...

Wall Street expects CoreWeave stock to jump more than 55% over the coming 12 months, making now, right before 2026, a good ...

Data center power demand is projected to grow by 160% by 2030, creating unprecedented opportunities for energy infrastructure companies. Nuclear power is experiencing a renaissance as hyperscalers ...

TD Bank (TSX:TD) and other Big Six banks blew reported good results for their latest quarters. Canadian big‑bank fundamentals ...

Sales from the pharmaceutical company's three top drugs are soaring. There are lots of great stocks in this sector. But one ...

Opendoor Technologies (NASDAQ: OPEN) is probably not a stock you heard much about last year -- it lost nearly two-thirds of ...

Analyst identifies undervalued retail stocks, highlighting long-term opportunities in Nike, Lululemon and Gildan.

AI stocks pulled back, but strategist Ryan Modesto highlights three names he says offer strong “buy the dip” potential as demand continues to outpace supply.

Get Thomas Hughes’ 5 top stock picks for December, including two major AI names, a fast-growing GPU-as-a-service player, a ...

The Vanguard Mega Cap Growth ETF(NYSEMKT: MGK) is an exchange-traded fund that invests exclusively in America's largest ...

A strong year for initial public offerings on Wall Street has fizzled out due to the government shutdown and a cautious turn ...